Developer docs
API playgroundTry for free, no card

Search company profiles

Serf

Full company profile

uuid000ctyk

Namestring
Serf
Legal namestring
SOCIETE D'ETUDES DE RECHERCHES ET DE FABRICATION S.A.S.
Websiteurl
serf.fr
Company typeenum
Private
Founded yearint
1973
Descriptiontext

SERF (Société d'Etude, de Recherche et de Fabrication) is a French orthopedic implant manufacturer founded in 1973 by André Rambert and headquartered in Décines-Charpieu, France. The company invented the Dual Mobility concept for hip arthroplasty in 1975 through collaboration with Professor Gilles Bousquet, a design that combines two bearing surfaces (small articulation between femoral head and insert, large articulation between insert and cup) to reduce dislocation risk and increase range of motion. SERF's product portfolio spans three segments: hip implants (NOVAE dual mobility acetabular cups, HYPE cups, CHIBF E bipolar cups, HYPE and Libra femoral stems, SAGITTA EVL R revision stems), knee implants (MADISON total knee prosthesis in PS and UC versions, acquired from Implanet in 2021), and extremity/foot implants (F.A.S.T. screws, plates, TOE implants, varisation staples). The company also provides SERF Planning Software, a 2D web-based pre-operative planning tool.

SERF generates revenue primarily through direct sales of orthopedic implants to healthcare establishments in France and Italy, supplemented by an international distribution network covering 25+ countries across Europe, Africa, the Americas, Asia-Pacific, and the Middle-East. The company employs consignment (Dépôt) and loan (Prêt) inventory models at customer sites, with revenue recognized upon implant use. Pricing is quote-based, ex-works Décines-Charpieu, with a minimum order of 70 EUR excluding tax, and includes additional fees for loan services. SERF also generates professional services revenue through the SERF Excellence training platform (webinars, cadaver labs, expert surgeon sessions). The company is certified to ISO 13485:2016, holds CE marking under EU MDR 2017/745, FDA compliance via 21 CFR Part 820, and ANVISA GMP accreditation.

As of March 2024, SERF was acquired by Stryker Corporation to expand Stryker's shoulder replacement portfolio with Dual Mobility Cup technologies. Prior to that, SERF had operated as a subsidiary of the MENIX Group since 2009. The company maintains wholly-owned subsidiaries including SERF Extremity (2014, foot implants), SERF Italy (2019, Pesaro), and SERF Inc. USA (2022, North American market entry). Headcount is reported at 51-100 employees in firmographic data, with the careers page indicating 150+; exact revenue figures are not publicly disclosed.

Short descriptiontext

SERF is a French orthopedic implant manufacturer (founded 1973) that invented the Dual Mobility concept for hip replacement. It sells hip, knee, and extremity implants to surgeons and hospitals globally via direct sales and a 25+ country distributor network.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersDécines-charpieu, France
HQ citystring
Décines-charpieu
HQ countrystring
France
HQ regionstring
Europe
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
orthopedic implants, hip replacement, knee prosthesis, dual mobility cups, extremity fixation
Industry2 codes
1Orthopedic Joint Reconstruction Implants (Hip/Knee/Shoulder/Elbow/Ankle)
CodeHLAHAEAAPrimaryYes
2Orthopedic Trauma & Extremities Fixation (Plates/Screws/Nails/External Fixation)
CodeHLAHAEABPrimaryNo
NAICS code2 codes
  • Surgical Appliance and Supplies Manufacturing339113
  • Surgical and Medical Instrument Manufacturing339112
SIC code1 code
  • Orthopedic, Prosthetic & Surgical Appliances & Supplies3842
Product category
Orthopedic Implants
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Orthopedic Implant Sales
TypeHardware Sales
Description

Sale of hip, knee, and foot/extremity implants to healthcare establishments. Products include acetabular cups, femoral stems, knee prostheses, and associated instruments. Revenue generated through direct sales to hospitals and clinics.

serf.fr
2Consignment and Loan Services
TypeHardware Sales
Description

SERF places inventory at customer sites (consignment Dépôt model) and provides temporary loan equipment (Prêt) for specific surgeries. Revenue recognized upon implant use or loan fees for unused equipment returned.

serf.fr
3Professional Services
TypeProfessional Services
Description

Training and education services through SERF Excellence platform, including webinars, cadaver labs, and expert surgeon-led sessions. Associated service fees apply.

serf.fr
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Supply Chain
Pricing details2 tiers
1Standard implant pricing
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Prices determined at time of order based on applicable regulations. Ex-works Décines-Charpieu, excluding VAT. Minimum order 70 EUR HT.

serf.fr
2Loan service fees
ModelOtherBilling cadencePay-as-you-go
Notes

Prêt sans pose: 350 EUR; Non-respect date enlèvement: 50 EUR/day; Prêt du jour: 200 EUR; Absent navette: 400 EUR/basket; Late return beyond 1 month: full product price

serf.fr
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 2 records shown
1SERF Excellence
Description

Platform for healthcare professionals to exchange practices and develop expertise with expert surgeons

serf.fr
+1 more record
Core offering1 text field

SERF designs, manufactures and sells orthopedic implants for hip, knee and foot/extremity surgery, with the Dual Mobility acetabular cup concept (invented 1975 by André Rambert and Prof. Gilles Bousquet) as its flagship. Its range covers acetabular cups, femoral stems including revision stems, the MADISON total knee prosthesis, and F.A.S.T. extremity screws, plates and staples, sold to hospitals, surgeons and medical device distributors in more than 25 countries under consignment and loan inventory models.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 98% survival rate at 8-year follow-up for cementless dual mobility cups in recurrent dislocation treatment
+3 more records
Product overview1 text field

SERF (Société d'Etude, de Recherche et de Fabrication) is a French medical device company founded in 1973 specializing in orthopedic implants. The company is the inventor of the Dual Mobility concept (1975) for hip replacement. SERF's product portfolio comprises three main categories: Hip implants (including NOVAE® dual mobility acetabular cups, HYPE® acetabular cups, CHIBF E bipolar cups, HYPE® stems, Libra® stems, and SAGITTA EVL R revision stems), Knee implants (MADISON total knee prosthesis in poster stabilized and ultracongruent versions), and Extremity/Foot implants (F.A.S.T.® screws, plates, TOE implants, varisation staples, percutaneous drills). The company also offers SERF Planning Software as a 2D web-based pre-operative planning tool. SERF products are distributed through direct sales and a global distribution network spanning Europe, Africa, Americas, Asia-Pacific, and Middle-East. The company operates as a subsidiary of the MENIX Group and was acquired by Stryker Corporation in March 2024.

Product and service14 records
1NOVAE® Acetabular Cup Range
CategoryHip implants
Description

Range of dual mobility acetabular cups for total hip replacement including cementless and cemented fixation options, eight implant variants with associated liners and reinforcement plates for primary and revision surgery. Targeted at orthopedic surgeons and hospitals performing total hip arthroplasty.

2HYPE® Acetabular Cup
CategoryHip implants
Description

Acetabular cup implementing the Dual Mobility concept for hip replacement, intended for use with HYPE femoral stems in total hip arthroplasty. Targeted at orthopedic surgeons performing hip replacement at hospitals and surgical centers.

3CHIBF E Bipolar Cup
CategoryHip implants
Description

Bipolar cup providing Dual Mobility concept implementation for hip procedures, used in hemiarthroplasty contexts where dual articulation is required. For orthopedic surgeons and hospitals performing partial and bipolar hip procedures.

4HYPE® Stems
CategoryHip implants
Description

Femoral stems designed for total hip arthroplasty in combination with HYPE acetabular cups. Used by orthopedic surgeons and hospitals performing hip replacement.

5Libra® Stems
CategoryHip implants
Description

Femoral stem components for total hip replacement, part of SERF's hip implant family. Used by orthopedic surgeons for primary hip arthroplasty.

6SAGITTA EVL R Revision Stem
CategoryHip implants
Description

Anatomical femoral revision implant with or without femoral flap, using cementless HA coating fixation and distal locking with two screws for primary vertical and rotational stability, available in three lengths and multiple diameters. Designed for orthopedic surgeons performing hip revision surgery.

7MADISON Total Knee Prosthesis (TKP)
CategoryKnee implants
Description

Primary total knee prosthesis available in two versions (Postero Stabilized and Ultracongruent) with four configuration options (fixed or mobile insert on a single baseplate), supporting conventional, augmented reality and custom-made instrument techniques. Manufactured by Implanet and distributed by SERF. For orthopedic surgeons performing total knee replacement.

8F.A.S.T.® Screws
CategoryExtremity implants
Description

Orthopedic screws designed for foot and extremity surgical procedures. For orthopedic and podiatric surgeons performing foot/extremity surgery in hospitals and surgical centers.

9F.A.S.T.® Compression Plates
CategoryExtremity implants
Description

Compression plates used in foot and extremity surgical procedures for bone fixation. For orthopedic and podiatric surgeons performing foot/extremity surgery.

10TOE F.A.S.T.® Implant
CategoryExtremity implants
Description

Toe implant designed for foot and forefoot surgical procedures, particularly corrective toe surgery. For orthopedic and podiatric surgeons performing extremity procedures.

11F.A.S.T.® Varisation Staples
CategoryExtremity implants
Description

Staples used in foot and extremity varisation (osteotomy correction) procedures. For orthopedic and podiatric surgeons.

12F.A.S.T.® Percutaneous Drills
CategoryExtremity implants
Description

Percutaneous drills for minimally invasive foot and extremity surgical procedures, including techniques such as percutaneous Chevron. For orthopedic and podiatric surgeons.

13F.A.S.T.® Sectionable Screws
CategoryExtremity implants
Description

Sectionable screws used in foot and extremity surgical procedures where screw length customization is needed intraoperatively. For orthopedic and podiatric surgeons.

14SERF Planning Software
CategorySurgical planning software
Description

2D web-based pre-operative planning tool accessible without installation or download for planning total hip arthroplasty on patient X-rays, with implant size indicators and orientation without projection bias. Available on PC or Mac. For orthopedic surgeons planning hip replacement.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership6 partners
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2015-01-01
Description

Digital orthopedic solutions company that joined MENIX Group in 2015, operating alongside SERF under the group umbrella.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2012-01-01
Description

Dental activity transferred from SERF to GLOBAL D (formerly TEKKA) in 2013 following MENIX acquisition. GLOBAL D handles all dental implant business while SERF focuses exclusively on orthopedic implants.

3Groupe MENIX
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2009-01-01
Description

SERF joined the MENIX Group in 2009 under Patrick Rondot's leadership. MENIX is a French holding company grouping orthopedic, dental implantology, and cranio-maxillofacial surgery brands including Dedienne Santé, Global D, and OneOrtho Médical.

serf.fr
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2008-01-01
Description

Original DEDIENNE SANTE acquired by MENIX Group in 2008 to form the group's orthopedic division alongside SERF.

5GMED
Strategic tierCoreTypeTechnology or Integration
Description

Notified body that certifies SERF's quality management system (ISO 13485:2016) and issues CE marking for medical devices per EU MDR 2017/745.

serf.fr
Strategic tierCoreTypeOEM/ Whitelabel/ Licensing Partner
Description

MADISON total knee prosthesis manufactured by Implanet and distributed exclusively by SERF under distribution agreement.

Recent move10 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

DePuy Synthes, part of J&J MedTech, is a top-three global orthopedic implant company with extensive hip, knee, and trauma portfolios. Directly comparable as a competitor selling hip stems, acetabular cups (including dual mobility options), and knee prostheses to the same hospital channels as SERF.

TypeBroad incumbent
Description

Stryker is the acquirer of SERF and one of the world's largest orthopedic implant companies with broad hip, knee, shoulder, and trauma portfolios. Highly comparable as both a competing supplier of dual mobility cups (e.g., ADM, MDM) and now the corporate parent integrating SERF's technology.

TypeBroad incumbent
Description

Arthrex is a leading orthopedic device company with a strong extremity/foot and ankle portfolio alongside sports medicine. Comparable to SERF in the foot/extremity segment (F.A.S.T. screws, plates, TOE implants) where Arthrex is a meaningful competitor.

TypeDirect peer
Description

Corin is a UK-based orthopedic implant specialist with a leading dual mobility hip portfolio (e.g., Trinity Dual Mobility) and growing presence in connected/robotic surgery. Comparable to SERF as a similarly sized dual mobility-focused specialist competing for the same surgeon and hospital customers.

TypeBroad incumbent
Description

Smith+Nephew operates a sizable Orthopaedics business spanning hip, knee, and trauma, with dual mobility cup options (PolarSTEM, Anthology). Comparable as a competing global orthopedic implant incumbent pursuing the same dual mobility and primary/revision arthroplasty markets.

TypeDirect peer
Description

Adler Ortho is an Italian orthopedic implant manufacturer with hip, knee, and extremity products. Comparable to SERF as a similarly sized European niche orthopedic specialist competing in hip arthroplasty and serving the same Southern European hospital channel.

TypeDirect peer
Description

Mathys is a Swiss orthopedic specialist within Enovis focused on hip and knee implants, including dual mobility cups and revision systems. Comparable to SERF as a similarly sized European hip/knee specialist with comparable revision and dual mobility offerings.

TypeEmerging player
Description

Medacta is a Swiss orthopedic implant specialist known for hip stems, knee prostheses, and minimally invasive techniques, with a strong dual mobility offering (e.g., Mpact DM). Comparable to SERF as a European mid-sized specialist expanding hip and knee portfolios globally.

TypeBroad incumbent
Description

Enovis owns Mathys and a portfolio of orthopedic reconstruction brands including hip stems, dual mobility cups, and extremity products. Comparable to SERF as a diversified orthopedic platform competing in primary hip arthroplasty and extremities, particularly in European markets.

TypeBroad incumbent
Description

Zimmer Biomet is a global leader in hip and knee reconstruction, including dual mobility cup offerings (G7 Dual Mobility). Comparable to SERF as a competing implant manufacturer serving the same orthopedic surgeon and hospital customer base across primary and revision arthroplasty.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries3 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Serf

Orthopedic Implantsserf.fr

SERF is a French orthopedic implant manufacturer (founded 1973) that invented the Dual Mobility concept for hip replacement. It sells hip, knee, and extremity implants to surgeons and hospitals globally via direct sales and a 25+ country distributor network.

What Serf does

SERF (Société d'Etude, de Recherche et de Fabrication) is a French orthopedic implant manufacturer founded in 1973 by André Rambert and headquartered in Décines-Charpieu, France. The company invented the Dual Mobility concept for hip arthroplasty in 1975 through collaboration with Professor Gilles Bousquet, a design that combines two bearing surfaces (small articulation between femoral head and insert, large articulation between insert and cup) to reduce dislocation risk and increase range of motion. SERF's product portfolio spans three segments: hip implants (NOVAE dual mobility acetabular cups, HYPE cups, CHIBF E bipolar cups, HYPE and Libra femoral stems, SAGITTA EVL R revision stems), knee implants (MADISON total knee prosthesis in PS and UC versions, acquired from Implanet in 2021), and extremity/foot implants (F.A.S.T. screws, plates, TOE implants, varisation staples). The company also provides SERF Planning Software, a 2D web-based pre-operative planning tool.

SERF generates revenue primarily through direct sales of orthopedic implants to healthcare establishments in France and Italy, supplemented by an international distribution network covering 25+ countries across Europe, Africa, the Americas, Asia-Pacific, and the Middle-East. The company employs consignment (Dépôt) and loan (Prêt) inventory models at customer sites, with revenue recognized upon implant use. Pricing is quote-based, ex-works Décines-Charpieu, with a minimum order of 70 EUR excluding tax, and includes additional fees for loan services. SERF also generates professional services revenue through the SERF Excellence training platform (webinars, cadaver labs, expert surgeon sessions). The company is certified to ISO 13485:2016, holds CE marking under EU MDR 2017/745, FDA compliance via 21 CFR Part 820, and ANVISA GMP accreditation.

As of March 2024, SERF was acquired by Stryker Corporation to expand Stryker's shoulder replacement portfolio with Dual Mobility Cup technologies. Prior to that, SERF had operated as a subsidiary of the MENIX Group since 2009. The company maintains wholly-owned subsidiaries including SERF Extremity (2014, foot implants), SERF Italy (2019, Pesaro), and SERF Inc. USA (2022, North American market entry). Headcount is reported at 51-100 employees in firmographic data, with the careers page indicating 150+; exact revenue figures are not publicly disclosed.

Serf firmographics

Firmographics
Name
Serf
Legal name
SOCIETE D'ETUDES DE RECHERCHES ET DE FABRICATION S.A.S.
Website
https://serf.fr
Company type
Private
Founded year
1973
Operating status
Operating
Headcount range
51–100 employees
Short description
SERF is a French orthopedic implant manufacturer (founded 1973) that invented the Dual Mobility concept for hip replacement. It sells hip, knee, and extremity implants to surgeons and hospitals globally via direct sales and a 25+ country distributor network.
Ownership category
akta.pro rank

Serf industry classification

Industry
Product category
Orthopedic Implants
NAICS
Surgical Appliance and Supplies Manufacturing (339113), Surgical and Medical Instrument Manufacturing (339112)
SIC
Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)
akta.pro primary industry
Orthopedic Joint Reconstruction Implants (Hip/Knee/Shoulder/Elbow/Ankle) (HLAHAEAA)
akta.pro secondary industry
Orthopedic Trauma & Extremities Fixation (Plates/Screws/Nails/External Fixation) (HLAHAEAB)

Keywords

  • Orthopedic implants
  • Hip replacement
  • Knee prosthesis
  • Dual mobility cups
  • Extremity fixation

Where Serf is headquartered

Location

Headquarters

HQ city
Décines-charpieu
HQ country
France
HQ region
Europe

Offices3 records

Markets served

Serf business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Supply Chain

Revenue model

  1. Orthopedic Implant Sales: Sale of hip, knee, and foot/extremity implants to healthcare establishments. Products include acetabular cups, femoral stems, knee prostheses, and associated instruments. Revenue generated through direct sales to hospitals and clinics.
  2. Consignment and Loan Services: SERF places inventory at customer sites (consignment Dépôt model) and provides temporary loan equipment (Prêt) for specific surgeries. Revenue recognized upon implant use or loan fees for unused equipment returned.
  3. Professional Services: Training and education services through SERF Excellence platform, including webinars, cadaver labs, and expert surgeon-led sessions. Associated service fees apply.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goStandard implant pricing
OtherPay-as-you-goLoan service fees

Go-to-market motion2 records

Distribution channels3 records

Marketing channels4 records

Serf product offering

Product offering

Core offering

SERF designs, manufactures and sells orthopedic implants for hip, knee and foot/extremity surgery, with the Dual Mobility acetabular cup concept (invented 1975 by André Rambert and Prof. Gilles Bousquet) as its flagship. Its range covers acetabular cups, femoral stems including revision stems, the MADISON total knee prosthesis, and F.A.S.T. extremity screws, plates and staples, sold to hospitals, surgeons and medical device distributors in more than 25 countries under consignment and loan inventory models.

Product overview

SERF (Société d'Etude, de Recherche et de Fabrication) is a French medical device company founded in 1973 specializing in orthopedic implants. The company is the inventor of the Dual Mobility concept (1975) for hip replacement. SERF's product portfolio comprises three main categories: Hip implants (including NOVAE® dual mobility acetabular cups, HYPE® acetabular cups, CHIBF E bipolar cups, HYPE® stems, Libra® stems, and SAGITTA EVL R revision stems), Knee implants (MADISON total knee prosthesis in poster stabilized and ultracongruent versions), and Extremity/Foot implants (F.A.S.T.® screws, plates, TOE implants, varisation staples, percutaneous drills). The company also offers SERF Planning Software as a 2D web-based pre-operative planning tool. SERF products are distributed through direct sales and a global distribution network spanning Europe, Africa, Americas, Asia-Pacific, and Middle-East. The company operates as a subsidiary of the MENIX Group and was acquired by Stryker Corporation in March 2024.

Differentiator

Problem solved

Functional benefit

Brands

  • SERF Excellence: Platform for healthcare professionals to exchange practices and develop expertise with expert surgeons
  • SERF Extremity

Products and services

  • NOVAE® Acetabular Cup Range Range of dual mobility acetabular cups for total hip replacement including cementless and cemented fixation options, eight implant variants with associated liners and reinforcement plates for primary and revision surgery. Targeted at orthopedic surgeons and hospitals performing total hip arthroplasty.
  • HYPE® Acetabular Cup Acetabular cup implementing the Dual Mobility concept for hip replacement, intended for use with HYPE femoral stems in total hip arthroplasty. Targeted at orthopedic surgeons performing hip replacement at hospitals and surgical centers.
  • CHIBF E Bipolar Cup Bipolar cup providing Dual Mobility concept implementation for hip procedures, used in hemiarthroplasty contexts where dual articulation is required. For orthopedic surgeons and hospitals performing partial and bipolar hip procedures.
  • HYPE® Stems Femoral stems designed for total hip arthroplasty in combination with HYPE acetabular cups. Used by orthopedic surgeons and hospitals performing hip replacement.
  • Libra® Stems Femoral stem components for total hip replacement, part of SERF's hip implant family. Used by orthopedic surgeons for primary hip arthroplasty.
  • SAGITTA EVL R Revision Stem Anatomical femoral revision implant with or without femoral flap, using cementless HA coating fixation and distal locking with two screws for primary vertical and rotational stability, available in three lengths and multiple diameters. Designed for orthopedic surgeons performing hip revision surgery.
  • MADISON Total Knee Prosthesis (TKP) Primary total knee prosthesis available in two versions (Postero Stabilized and Ultracongruent) with four configuration options (fixed or mobile insert on a single baseplate), supporting conventional, augmented reality and custom-made instrument techniques. Manufactured by Implanet and distributed by SERF. For orthopedic surgeons performing total knee replacement.
  • F.A.S.T.® Screws Orthopedic screws designed for foot and extremity surgical procedures. For orthopedic and podiatric surgeons performing foot/extremity surgery in hospitals and surgical centers.
  • F.A.S.T.® Compression Plates Compression plates used in foot and extremity surgical procedures for bone fixation. For orthopedic and podiatric surgeons performing foot/extremity surgery.
  • TOE F.A.S.T.® Implant Toe implant designed for foot and forefoot surgical procedures, particularly corrective toe surgery. For orthopedic and podiatric surgeons performing extremity procedures.
  • F.A.S.T.® Varisation Staples Staples used in foot and extremity varisation (osteotomy correction) procedures. For orthopedic and podiatric surgeons.
  • F.A.S.T.® Percutaneous Drills Percutaneous drills for minimally invasive foot and extremity surgical procedures, including techniques such as percutaneous Chevron. For orthopedic and podiatric surgeons.
  • F.A.S.T.® Sectionable Screws Sectionable screws used in foot and extremity surgical procedures where screw length customization is needed intraoperatively. For orthopedic and podiatric surgeons.
  • SERF Planning Software 2D web-based pre-operative planning tool accessible without installation or download for planning total hip arthroplasty on patient X-rays, with implant size indicators and orientation without projection bias. Available on PC or Mac. For orthopedic surgeons planning hip replacement.

Quantifiable outcome

  • 98% survival rate at 8-year follow-up for cementless dual mobility cups in recurrent dislocation treatment
  • +3 more outcomes

Companies that use Serf

Customer profile

Named customers1 record

Segments2 records

Ideal customer profiles2 records

Serf technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

Serf partnerships and signals

Strategic signal

Partnerships

Six partnerships are on record, tiered minor and core.

  • OneOrtho MédicalminorStrategic or Co-development Partner · 1 January 2015Digital orthopedic solutions company that joined MENIX Group in 2015, operating alongside SERF under the group umbrella.
  • GLOBAL DcoreStrategic or Co-development Partner · 1 January 2012Dental activity transferred from SERF to GLOBAL D (formerly TEKKA) in 2013 following MENIX acquisition. GLOBAL D handles all dental implant business while SERF focuses exclusively on orthopedic implants.
  • Groupe MENIXcoreStrategic or Co-development Partner · 1 January 2009SERF joined the MENIX Group in 2009 under Patrick Rondot's leadership. MENIX is a French holding company grouping orthopedic, dental implantology, and cranio-maxillofacial surgery brands including Dedienne Santé, Global D, and OneOrtho Médical.
  • Dedienne SantéminorStrategic or Co-development Partner · 1 January 2008Original DEDIENNE SANTE acquired by MENIX Group in 2008 to form the group's orthopedic division alongside SERF.
  • GMEDcoreTechnology or IntegrationNotified body that certifies SERF's quality management system (ISO 13485:2016) and issues CE marking for medical devices per EU MDR 2017/745.
  • ImplanetcoreOEM/ Whitelabel/ Licensing PartnerMADISON total knee prosthesis manufactured by Implanet and distributed exclusively by SERF under distribution agreement.

Scale indicators4 records

Recent moves10 records

Expansion highlights6 records

Serf competitors and assessment

Company assessment

Broad incumbents

  • DePuy Synthes (Johnson & Johnson): DePuy Synthes, part of J&J MedTech, is a top-three global orthopedic implant company with extensive hip, knee, and trauma portfolios. Directly comparable as a competitor selling hip stems, acetabular cups (including dual mobility options), and knee prostheses to the same hospital channels as SERF.
  • Stryker Corporation: Stryker is the acquirer of SERF and one of the world's largest orthopedic implant companies with broad hip, knee, shoulder, and trauma portfolios. Highly comparable as both a competing supplier of dual mobility cups (e.g., ADM, MDM) and now the corporate parent integrating SERF's technology.
  • Arthrex: Arthrex is a leading orthopedic device company with a strong extremity/foot and ankle portfolio alongside sports medicine. Comparable to SERF in the foot/extremity segment (F.A.S.T. screws, plates, TOE implants) where Arthrex is a meaningful competitor.
  • Smith+Nephew: Smith+Nephew operates a sizable Orthopaedics business spanning hip, knee, and trauma, with dual mobility cup options (PolarSTEM, Anthology). Comparable as a competing global orthopedic implant incumbent pursuing the same dual mobility and primary/revision arthroplasty markets.
  • Enovis Corporation (formerly Colson Associates / DJO): Enovis owns Mathys and a portfolio of orthopedic reconstruction brands including hip stems, dual mobility cups, and extremity products. Comparable to SERF as a diversified orthopedic platform competing in primary hip arthroplasty and extremities, particularly in European markets.
  • Zimmer Biomet: Zimmer Biomet is a global leader in hip and knee reconstruction, including dual mobility cup offerings (G7 Dual Mobility). Comparable to SERF as a competing implant manufacturer serving the same orthopedic surgeon and hospital customer base across primary and revision arthroplasty.

Direct peers

  • Corin: Corin is a UK-based orthopedic implant specialist with a leading dual mobility hip portfolio (e.g., Trinity Dual Mobility) and growing presence in connected/robotic surgery. Comparable to SERF as a similarly sized dual mobility-focused specialist competing for the same surgeon and hospital customers.
  • Adler Ortho: Adler Ortho is an Italian orthopedic implant manufacturer with hip, knee, and extremity products. Comparable to SERF as a similarly sized European niche orthopedic specialist competing in hip arthroplasty and serving the same Southern European hospital channel.
  • Mathys (Enovis): Mathys is a Swiss orthopedic specialist within Enovis focused on hip and knee implants, including dual mobility cups and revision systems. Comparable to SERF as a similarly sized European hip/knee specialist with comparable revision and dual mobility offerings.

Emerging players

  • Medacta International: Medacta is a Swiss orthopedic implant specialist known for hip stems, knee prostheses, and minimally invasive techniques, with a strong dual mobility offering (e.g., Mpact DM). Comparable to SERF as a European mid-sized specialist expanding hip and knee portfolios globally.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

Serf social profiles

Digital presence

Serf compliance and trust

Trust signal

Compliance4 records

Serf financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Serf leadership team

Management profile

Number of profiles

Profiles1 record

Serf subsidiaries and ownership

Company hierarchy

Subsidiaries3 records

Serf funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Serf M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Serf

What does Serf do?

SERF designs, manufactures and sells orthopedic implants for hip, knee and foot/extremity surgery, with the Dual Mobility acetabular cup concept (invented 1975 by André Rambert and Prof. Gilles Bousquet) as its flagship. Its range covers acetabular cups, femoral stems including revision stems, the MADISON total knee prosthesis, and F.A.S.T. extremity screws, plates and staples, sold to hospitals, surgeons and medical device distributors in more than 25 countries under consignment and loan inventory models.

Is Serf a public or private company?

Serf is a private company. It is classified as corporate owned and is currently operating.

When was Serf founded?

Serf was founded in 1973. It employs 51 to 100 people.

Where is Serf based?

Serf is headquartered in Décines-charpieu, France, in the Europe region.

How does Serf make money?

Three revenue lines are on record. Orthopedic Implant Sales are the primary driver. The others are consignment and Loan Services and professional Services.

Who are Serf's main competitors?

Broad incumbents on record are DePuy Synthes (Johnson & Johnson), Stryker Corporation, Arthrex, Smith+Nephew, Enovis Corporation (formerly Colson Associates / DJO) and Zimmer Biomet. Direct peers are Corin, Adler Ortho and Mathys (Enovis). Medacta International is listed as an emerging player.

Does Serf have an API?

No public API is recorded for Serf.

What industry is Serf in?

Serf's product category is Orthopedic Implants. Its primary akta.pro industry code is HLAHAEAA, Orthopedic Joint Reconstruction Implants (Hip/Knee/Shoulder/Elbow/Ankle), with a secondary code of HLAHAEAB, Orthopedic Trauma & Extremities Fixation (Plates/Screws/Nails/External Fixation). Its NAICS code is 339113 and its SIC code is 3842.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
openPR.comKey Factors and Emerging Trends Shaping the Shoulder Replacement Devices Market LandscapeThe shoulder replacement devices market is projected to reach $2.41 billion by 2030, growing at a CAGR of 7.9%, driven by advancements in patient-specific implants, robotic-assisted surgeries, and biomaterials. In March 2024, Stryker Corporation acquired France-based SERF SAS to expand its shoulder replacement portfolio with technologies including the Dual Mobility Cup. Additionally, Zimmer Biomet Holdings Inc. received FDA 510(k) clearance in January 2024 for its Osseo Fit Stemless Shoulder System featuring OsseoTi porous metal technology.openPR.comKnee Implants Market Overview, Current Trends, and Key Player AnalysisThe global knee implants market is projected to reach $16.67 billion by 2030, growing at a compound annual growth rate of 6.7%, driven by advancements in robotic-assisted surgeries, increasing outpatient orthopedic procedures, and rising demand for patient-specific implants. In March 2024, Stryker Corporation acquired France-based SERF SAS to expand its orthopedic joint replacement portfolio across Europe, following the launch of its Mako Total Knee 2.0 robotic surgical system in March 2023. The market segmentation covers product types including total, partial, and revision knee replacements, along with various materials and fixation methods.StrykerStryker completes acquisition of SERF SASStryker has completed its acquisition of SERF SAS, a France-based joint replacement company, from the seller Menix. This transaction expands Stryker's global orthopaedic portfolio and strengthens its presence in the European market.BioSpaceStryker completes acquisition of SERF SASStryker has completed the acquisition of SERF SAS, a France-based joint replacement company, from its previous owner Menix. This transaction strengthens Stryker's global orthopaedic portfolio and expands its presence in the European market through SERF's specialized hip implant innovations.MassDeviceStryker completes acquisition of SERF SASStryker has completed its acquisition of SERF SAS, a France-based joint replacement company previously owned by Menix. This transaction strengthens Stryker's global orthopedic portfolio and expands its presence in the European market.Investing.comEarnings call: Stryker reports over $20 billion in 2023 sales, eyes future growth By Investing.comStryker reported over $20 billion in sales for 2023, with Q4 and full-year adjusted EPS of $3.46 and $10.60, up 15% and 13% year-over-year. The company guided 2024 organic sales growth to 7.5%-9% and adjusted EPS to $11.70-$12. It also plans M&A, including a SERF acquisition expected to close this quarter.StrykerStryker announces intent to acquire SERF SAS, enhancing its global joint replacement leadershipStryker has executed a binding offer to acquire SERF SAS, a France-based joint replacement company, from Menix. This acquisition is intended to enhance Stryker's global joint replacement leadership and complement its existing presence in Europe, with the deal expected to close in the first quarter of 2024 subject to regulatory approvals.